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CHROMATOGRAPHIC SEPARATION AND ISOLATION OF 
SKIN TEST ACTIVE COMPONENTS OF HISTOPLASMIN
CHAPTER I 
INTRODUCTION
The medical significance of histoplasmosis has become increas­
ingly evident in the last two decades. Reported cases of this disease 
in human beings and lower animals have risen sharply since Darling's 
initial observation in 1905 (6). Loosli, et al. (25) suggested that 
30,000,000 people in the United States alone have been exposed to the 
etiological agent Histoplasma capsulatum, as determined by a positive 
skin test reaction to histoplasmin. Furcolow (13) estimated that 
500,000 new cases of histoplasmosis could be expected each year in 
the United States.
Numerous epidemiologists have studied the geographic distri­
bution of human histoplasmosis utilizing roentgenography and detection 
of infection allergy. Christie and Peterson (4) and Palmer (31) 
pioneered such epidemiological surveys in the early 1940's. Endeavors 
by these investigators and others (10, 14, 33, 45) have been partially 
successful in delineating endemic areas of histoplasmosis (Figure 1). 
The major obstacles in interpretation of these data have been vari­
ability of skin test antigens and cross reactivity with other mycoses.
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Figure 1. Geographic Distribution of Histoplasmin Skin Test 
Sensitivity.
3The antigens most often used for detection of infection allergy 
in early epidemiological investigations and used by most clinicians at 
the present time are crude mycelial growth filtrates of H. capsulatum.
Van Pernis, et al. (48) were first to use a crude mycelial growth 
filtrate for the study of histoplasmosis in 1941. They demonstrated
cutaneous reactions in an infected human patient, experimentally infected
mice and performed serological tests (complement fixations and quali­
tative precipitin tests) utilizing a 24 to 48 day old glucose broth 
filtrate as antigen. Zarafonetis, (51) utilizing William's synthetic 
medium, prepared a 7 week old mycelial growth filtrate which he called 
"histoplasmin". Christie (4) produced skin test antigen used in the 
initial survey conducted by Peterson and himself, using dextrose broth
for cultivation of the mycelial phase of H. capsulatum. This is referred
to as the "Vanderbilt Product."
Emmons (11) recognized the necessity for standardization of 
histoplasmin. He used Smith's asparagine medium (41) for the production 
of histoplasmin H-3 and determined its skin test potency by intradermal 
inoculation of H. capsulatum sensitized guinea pigs.
By 1945, the United States Public Health Service had become 
aware of the need for large scale epidemiological studies of histo­
plasmosis and practicing physicians were insisting on the availability 
of a reliable skin test product for clinical use. Since a large quantity 
of standardized H-3 was not available several relatively small lots of 
histoplasmin were prepared by Howell (40) and later pooled to form the 
skin test product designated as H-15. It was prepared using Long's 
synthetic medium and was standardized by comparison with H-3 histoplasmin
4using the technique of Emmons (11).
When wide spread use of H-15 was adopted in 1946, it was 
thought that a large enough quantity had been prepared to suffice for 
a number of years. However, the supply was so depleted by 1948 that a 
new product was needed. Accordingly, another relatively small pooled 
lot, designated H-4Ç, was prepared for interim use until-a more 
adequate supply could be provided. After testing several proposed 
lots, a new pooled product designated H-42 was selected (40).
h-42 histoplasmin is the product most widely used today and 
it is estimated that the supply now available will suffice for several 
years. Major pharmaceutical companies, in recent years have begun 
to produce and distribute histoplasmin commercially. Eli Lilly Company 
is currently marketing a product for serological use and detection 
of infection allergy.
Numerous investigators have attempted to fractionate various 
yeast cell preparations or filtrates of H. capsulatum. The basic ob­
jective, in most instances has been to increase specificity or sensitivity 
of the antigen or antigens involved in serological and infectious allergic 
reactions.
Van Pernis, et al., in 1941 precipitated a polysaccharide 
complex from histoplasmin with acetone (48). This complex elicited a 
positive skin test reaction in a patient with histoplasmosis. A few 
years later Salvin and Ribi (26) were able to separate the protoplasm 
from the intact yeast cell wall of H. capsulatum and demonstrate that 
both components participate in infectious allergic reactions. However, 
only the cell wall appeared to contain the antigenic component responsible
5for the fixation of complement in the presence of specific antisera.
Canadian investigators (24) have extracted yeast cells of H. 
capsulatum with a variety of organic solvents (pyridine, urea, acetone, 
phenol, trichloroacetic acid and etc.) showing that specific components 
participate in serological reactions. These investigations also suggest 
that antibodies, elicited by the various chemically characterized compon­
ents in human and experimental infections, appear at different times 
during the course of the disease (22 & 23).
Other investigators have prepared active skin test substances 
by ethanolic precipitation .and various deproteinization procedures (5,
8, 20, & 35). More recent approaches have utilized various cellulosic 
ion exchangers. Greene, et al., (16) exploiting such techniques have 
been able to isolate the "h" and "m" antigens of Heiner (18) from crude 
histoplasmin. Markowitz (27) and Fadula (12) also utilizing DEAE-cellulose 
have been able to corroborate the findings of Greene in isolation of sero­
logically active fractions of histoplasmin. Fadula (12) also has demon­
strated similar phenomena for several mycelial filtrates of Histoplasma 
duboisii.
The development, in recent years of various cross-linked 
dextran polymers has allowed a new approach to fractionation procedures 
based on molecular size and thus indirectly molecular weight. Hook, 
et al., (19) separated crude histoplasmin and yeast cell filtrates on 
a column of Sephadex G-200. High molecular weight fractions, separable 
from low molecular weight medium constituents and metabolic products, 
were serologically active in indirect fluorescent antibody tests, comple­
ment fixation tests and precipitin tests.
6The investigation reported here involves separation and 
collection of skin test active components of histoplasmin by such 
column chromatographic procedures. It would seem reasonable that if 
the skin test active component of histoplasmin could be separated from 
other extraneous substances, it could be dehydrated and thus lend 
itself to quantitation in terms of dry weight of active substance.
This would be desirable not only from the practical standpoint of 
processing, handling, and preservation, but also from the scientific 
point of view. Partial purification of the skin test active component 
of histoplasmin would be a step in the direction of elucidation and 
comprehension of its antigenic complexity.
In the mycobacterial field, the progress toward this goal 
received its- impetus with the preparation of a purified protein derivative 
(PPD) of tuberculin (39) and, more recently, of other antigens (1, 9).
Even though PPD is not a chemically pure substance, the active principle 
of tuberculin has been identified as a protein or protein complex. The 
dose of PPD is therefore expressed as milligrams of protein complex per 
unit volume of diluent.
The objective of the following series of investigations was to 
separate and isolate the principal skin test active component from crude 
histoplasmin. It also was anticipated that the dry weight or chemically 
estimated "skin test dose" could be determined.
CHAPTER II
MATERIALS AND METHODS
Preparation of Histoplasmins. Histoplasmins were prepared 
b y quantitative inoculation of sterile Smith's asparagine medium (41).
A 50 liter pyrex carboy containing the sterile medium was inoculated 
with a mycelial suspension of H. capsulatum. Aliquots (500 ml) of the 
homogenous inoculated medium were dispensed into 1 liter cotton 
plugged Erlenmeyer flasks. The flasks were incubated at 27 C and 
approximately 75% humidity to reduce dehydration with prolonged 
incubation. The flasks also were overlaid with foil allowing only the 
cotton plugs to be exposed to a General Electric germicidal lamp, to 
reduce contamination.
Histoplasmins were harvested after 5 months incubation by 
introduction of merthiolate (1:10,000) and double filtration through a 
Seitz filter. Crude histoplasmins were dispensed into 100 ml antigen 
bottles, sealed, labeled and stored at 4 C until fractionation. Table 
1 illustrates the isolates of H. capsulatum and inocula used in pre­
paration of the histoplasmins.
Fractionation of Histoplasmins. Aliquots of histoplasmin H-42 
and histoplasmins produced in our laboratory using the Scritchfield and 
Grand Island isolates of JL capsulatum were fractionated on a 2.5 x 40 cm
Table I. Preparation of Histoplasmin
H. capsulatum Culture
Age
(days)
Histoplasmin Inoculum Size 
Total Particles/ml Viable Particles/ml
Scritchfield 17 HT-1 A-5 1.5 X 10^ 1.0 X  10^
Scritchfield 25 HT-1 B-5 1.0 X 10^ 2.3 X 10^
Grand Island 16 HT-2 A-5 4.5 X 104 4.6 X  10^
fH-42 H-42 - -
00
*Courtesy of Dr. Carroll E. Palmer, U. S. Public Health Service
9column of Sephadex G-25 (Pharmacia Fine Chemicals, Uppsala, Sweden).
The fractionations were continuously monitored at wavelengths of 260 
and 280 millimicrons utilizing a Model 2000 multiple sample absorbance 
recorder. The effluent was collected in 2.5 ml aliquots and consecutive 
aliquots were pooled according to peaks of 280 mu absorption. The 
Sephadex G-25 column. Model 2000 multiple sample absorbance recorder 
(Gilford Instrument Laboratories, Inc., Oberlin, Ohio) and fraction 
collector are shown in Figure 2. All fractionations were performed at 20 C.
The pooled aliquots were concentrated under vacuum at 4 C.
Table 2 indicates the original volume of crude histoplasmin introduced 
onto the Sephadex G-25 column and the volume to which each respective 
fraction (pooled aliquots) was restored for skin testing and chemical 
characterization.
The fractions in turn were tested for detection of "infection 
allergy" by intradermal inoculation of infected and normal guinea pigs. 
Inoculum size was 0.1 ml and all induration readings reported were taken 
48 hours after initial inoculation.
Chemical Characterization of Histoplasmins. Protein was deter­
mined quantitatively by the modified Folin-Phenol method of Lowry (26), 
using crystalline bovine serum albumin as standard. Absorption at 280 mu 
also is indicative of proteinacious material (15 & 49). Various histoplas­
min fractions reacted with triketohydrindene hydrate (ninhydrin) which is 
a sensitive reagent for amino acids and amino acid residues (17).
Carbohydrate was determined with the enthrone reagent (28 & 38) 
and by the phenol-sulfuric acid technique of Dubois (7), using D-glucose 
as standard. Reducing sugars were determined colorimetrically using the
10
Figure 2. Apparatuses for Chromatographic Fractionation of 
Histoplasmin.
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Table 2. Fractionation of Histoplasmin
Histoplasmin Fractionation
No.
Sample Size 
Volume (ml)
Fractions
Volume (ml) 
after concentration
HT-1 A-5 *1. 25 5
2. 30 10
HT-1 B-5 *1. 20 10
HT-2 A-5 *1. 20 10
H-42 *1. 5 5
*2. 25 25
^Specific histoplasmin and its respective fractions tested 
for skin test potency and chemically characterized.
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arsenomolybdate and copper reagents of Somogyi (43). Qualitatively, the 
presence of nucleoprotein was based on the principle of Warburg and 
Christian (49), and confirmed by a positive diphenylamine reaction (29).
Electrophoretic Characterization of Histoplasmins. Crude histo­
plasmins and their respective fractions were subjected to paper electro­
phoresis at various hydrogen ion concentrations for 12 to 24 hr at 200 v.
Phosphate and veronal buffers of pH 5.5, 7.0 and 8.6 were prepared using 
(8.7 g KH2PO4 , 0.38 g NagHPO^), (3.5 g KH^PO^, 5.7 g NagHPO^) and (2.8 
g Barbital, 20.6 g Na-Barbital) per liter of distilled water respectively. 
Electrophoretic studies were performed using an E-C Pressure-plate Electro­
phoresis Cell (E-C Apparatus Corp., Philadelphia, Pa.) and Whatman No. 3 
mm paper strips. Paper strips were developed with ninhydrin (17) and
alkaline silver nitrate (47).
Skin Testing with Histoplasmins. Male albino guinea pigs 
approximately 6 months of age were used throughout these studies. All 
animals were tested initially with histoplasmin H-42 (1:25) and those 
exhibiting a positive reaction, i.e. 5mm or greater induration at 48 hr, 
were eliminated from the study.
Skin test negative animals (300-1000 g) were arranged by weight 
according to a preselected scheme into 51 regiments of 4 animals each. 
Sensitization was incurred by intraperitoneal inoculation of a viable 
mycelial suspension of H. capsulatum (Scritchfield) in a total volume of 
1 ml. Viability was determined by quantitative inoculation of mycelial 
suspension onto the surface of Sabouraud's dextrose agar plates. Plates 
were incubated at 25 C and colonies counted after an incubation period 
of 15 to 20 days. Table 3 shows the isolates of H. capsulatum, in­
oculation schedule and dose used to induce sensitization.
Table 3* Sensitization of Guinea Pigs
Test Group H. capsulatum' 
Isolate
Culture
Age
(days)
Inoculation
Schedule
(day)
Inoculum 
Total Parts
Size 
Viable Parts
HT-1 Scritchfield 30 1 9.4 X 10^ 1.4 X 10^
Scritchfield 34 5 :i.4 X 10^ 3.7 X 10^
Scritchfield 41 11 2.2 X 10^ 5.5 X 10^
Scritchfield 14 42 6.8 X 10^ 6.5 X 10^
Scritchfield 28 46 1.7 X 107 1.1 X 10^
Scritchfield 22 50 1.6 X 10^ 1.0 X 10^
Scritchfield 41 119 1.4 X 10^ 3.4 X 10^
Scritchfield 61 185 1.6 X 105 2.2 X 10^
w
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Control (non-infected) animals were randomly distributed 
throughout the regiments. The number varied from 10% initially to 
25% as the number of infected animals decreased with terminal disease 
and death.
Crude histoplasmins and their respective fractions were 
assayed for detection of "infection allergy" by intradermal inoculation 
(Mantoux test) of various concentrations of protein and carbohydrate 
or dry weight of material dissolved in 0.1 ml of diluent. Erythema and 
induration were measured and recorded 24 and 48 hr after inoculation. 
However, only 48 hr induration readings were used for the statistical 
calculations and thus for interpretation of results.
CHAPTER III
RESULTS
Crude histoplasmins were subjected to fractionation on all 
grades of Sephadex (G-200, G-150, G-lOO, G-75, G-50, G-25, G-15, 
and G-10) currently marketed by Pharmacia Fine Chemicals. It was 
determined that maximal separation of high molecular weight compounds 
passing the column early in the elution scheme was obtained with G-25.
Histoplasmin H-42. Figure 3 illustrates the elution pattern 
for a 25 ml sample of histoplasmin H-42 from the Sephadex column.
The arrows indicate the pooled 2.5 ml aliquots and thus represent the 
fractions. Respective fractions from left to right or with increasing 
tube number were labeled according to lower case Greek letters. Alpha, 
Beta, Gamma, Delta, Epsilon, Zeta, Nu, and Theta. The broken line 
represents the 280 mu readings expressed in per cent transmission 
along the ordinate axis and the dotted line the corresponding 260 mu 
readings.
Absorption at 280 mu indicates a small quantity of proteinacious 
material in the second or Beta fraction and a considerable quantity in 
the Zeta fraction. Also absorption at 260 mu, according to the principles 
of Warburg and Christian (49) would imply the presence of nucleoprotein 
in Delta, Epsilon and Zeta fractions with peak concentration in Delta.
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Figure 3. Elution Pattern for Histoplasmin H-42 from Sephadex 
G-25 Column measured at 260 mu and 280 mu.
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It also is significant that 260 mu absorption indicates the absence of 
nucleoprotein in the second or Beta fraction. These observations from 
spectrophotometric data were confirmed by the diphenylamine test (29).
One observes from Table 2 that the H-42 fractions were con­
centrated to initial starting volume of crude histoplasmin H-42 
fractionated. This theoretically should restore any individual com­
ponent or components occurring in a single fraction to its original 
concentration. Thus the fraction containing the active component or 
components should elicit a comparable cutaneous reaction to crude histo­
plasmin h -42 (1:25) upon testing infected and control animals. The only 
other alternative is the active component is present in more than one 
fraction, in which case adjacent fractions should exhibit similar but 
varying degrees of smaller positive reactions.
The table at the bottom of Figure 4 shows the colorimetric 
determination of sugar and protein expressed in micrograms per ml for 
the respective histoplasmin fractions. Total quantity of protein or 
carbohydrate per skin test dose can be determined by moving the decimal 
one place to the left, since volume of inoculum was 0.1 ml. The bottom 
line represents the ratio of carbohydrate to protein.
The histogram at the top of Figure 4 illustrates the mean 
results of animal testing. The ordinate axis shows 48 hr. induration 
expressed in millimeters and the abscissa the respective H-42 fraction 
tested.
These data indicate two active fractions: Beta exhibiting
maximal skin test activity and containing very little protein and 
carbohydrate and Zeta having considerable protein but negligible
18
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carbohydrate. It also is noteworthy that the ratio of carbohydrate to 
protein is very near one in the Beta fraction.
Electrophoresis studies of crude histoplasmin H-42 (1:25) 
shows 3 bands sensitive to ninhydrin (Figure 5). All 3 bands occurred 
in the Beta fraction but only one was stained with alkaline silver nitrate.
Histoplasmin HT-1 A-5. Figure 6 shows the elution pattern 
for a 25 ml sample of Scritchfield or HT-1 A-5 histoplasmin. The 
pattern is similar to that obtained for H-42 expept the integrated 
area under the 280 mu absorption curve implies considerably less total 
protein. This fact also is supported by the Lowry (26) protein deter­
minations. The arrows again represent the respective pooled 2.5 ml aliquots 
or fractions labeled by lower case Greek letters.
The chemical characterization and results of animal testing 
for the HT-1 A-5 fractions are illustrated in Figure 7. Beta fraction 
again yields maximal skin test activity and possesses only a small 
amount of protein and carbohydrate. The Nu fraction has the largest 
quantity of protein, 2200 ug/ml or 220 ug/test and shows the second 
peak of animal activity.
A 25 ml sample originally was applied to the Sephadex G-25 
column and the various fractions concentrated to 5 ml (Table 2). This 
represents a 5 fold concentration of the various HT-1 A-5 fractions 
with respect to original sample. Figure 7 shows 18 ug/ml of protein 
occurring in the HT-1 A-5 Beta fraction. This is twice the concentration 
of protein occurring in H-42 Beta fraction (Figure 4). It also is 
observed that a slightly larger, though not statistically significant, 
cutaneous reaction resulted (Figure 4 & 7).
20
Figure 5. Electrophoresis Paper Strips of Histoplasmin H-42, 
Crude Histoplasmin HT-1 A-5 and Histoplasmin HT-1 
A-5 Fractions Stained by Ninhydrin and Alkaline 
Silver Nitrate Methods.
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Electrophoresis studies of crude HT-1 A-5 histoplasmin showed 
4 ninhydrin sensitive bands (Figure 5). An additional band (blue-black 
band of strips 59 and 60) probably occurred but was masked due to high 
protein concentration. Strip 60 shows 3 bands for HT-1 A-5 Beta 
fraction. The purple band nearest the origin occurs In approximately 
the same position as the carbohydrate (47) band of strip 168.
Similar electrophoresis of Smith's asparagine medium and 
solutions of Its nitrogen containing components demonstrated the 
second band to the right of the original In crude HT-1 A-5 histoplasmin 
(strip 90) was asparagine and the fourth glycine (blue). Asparagine 
also was confirmed by the staining method of Pasleka (32). The 
characteristic staining reaction and mobility of glycine also accounts 
for 1 of the 3 bands occurring In crude H-42 histoplasmin and Its 
respective Beta fraction.
Histoplasmin HT-1 B-5. Histoplasmin HT-1 B-5 also was prepared 
using the Scritchfield Isolate of H. capsulatum. However, the Initial 
Inoculum was 200 times greater than for HT-1 A-5, with respect to 
viable partlcles/ml (Table 1) and the mycelial mat became submerged In 
the liquid medium between the second and third month of growth.
The Beta fraction (Figure 8) contained 1.33 ug of protein 
per test and elicited a mean skin test reaction slightly less than H-42 
Beta fraction (0.87 ug protein/test) and HT-1 A-5 Beta fraction (1.88 
ug protein/test). However, the HT-1 B-5 fractions were tested after 
the H-42 and HT-1 A-5 fractions, at which time the sensitized guinea 
pigs appeared to have waned with respect to reaction to crude H-42 (1:25).
Figure 9 shows that the fractionation for HT-1 B-5 was not as
24
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discrete as for histoplasmins H-42 and HT-1 A-5. This is reflected 
in a greater skin test response to HT-1 B-5 Gamma fraction (Figure 8).
The secondary peak of skin test activity characteristic of 
h-42 Zeta and HT-1 A-5 Nu was considerably reduced for HT-1 B-5 Zeta 
fraction. Figure 8 shows a marked reduction in detectable protein 
possibly explaining the smaller reaction.
Histoplasmin HT-2 A-5. HT-1 A-5 and B-5 involved skin testing 
studies of animals sensitized with the homologous isolate of H. Capsulatum. 
It is known from unpublished data (personal communication, Dr. Howard W. 
Larsh) that the Scritchfield isolate produces a potent crude skin test 
antigen. Therefore, heterologous or HT-2 A-5 histoplasmin and its 
respective fractions were tested on Scritchfield sensitized guinea pigs.
Figure 10 shows the indiscrete elution pattern for a 20 ml 
sample of HT-2 A-5 histoplasmin. Figure 11 illustrates the results of 
skin testing Scritchfield sensitized animals. The Beta and Gamma frac­
tions elicited cutaneous reactions comparable to H-42, HT-1 A-5 and 
HT-1 B-5 Beta fractions.
Various concentrations of Histoplasmins. The results presented 
above indicate two distinct fractions of the various histoplasmins 
examined are eluted from the Sephadex G-25 column which elicit skin 
test activity. Figure 12 shows the results of skin testing HT-1 (Scritch­
field sensitized) animals with similar protein concentrations of the 
various histoplasmin fractions. Beta and Gamma fractions were either 
concentrated or diluted to 1.5 ug/test and the remaining fractions 
diluted to 10 ug/test. Alpha and Theta fractions were not altered since 
they normally contained little or no protein and elicited insignificant 
skin reactions.
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These data (Figure 12) indicate that H-42 and HT-1 A-5 fractions 
of high protein concentration i.e. Epsilon, Zeta, and Nu essentially lose 
their activity at lower concentrations. However, HT-2 A-5 Nu fraction 
remained active. The concentration of this fraction was not increased 
to 10 ug/test but retained at 2.66 ug/test. This represents its protein 
concentration at initial testing (Figure 11) and its mean reaction size 
of 7.4 mm induration is almost identical to that obtained at initial 
testing (7.6 mm). Beta fractions for all histoplasmins remained active, 
in most instances eliciting skin test reactions comparable to those 
obtained at initial testing (Figure 4, 7, and 11).
Histoplasmin Purified Derivative. HPD was prepared by lyophili- 
zation of two separate 10 ml volumes of concentrated H-42 Beta fraction.
The dry material was weighed and then re-dissolved in sterile non- 
pyrogenic distilled water. The stock solutions were diluted to desired 
concentrations using volumetric pipettes.
Figure 13 shows the results of animal testing with various 
concentrations of re-dissolved HPD. Therefore it appears that 60 ug or
0.06 mg of HPD yields a 10 mm cutaneous reaction.
Protein and Total Carbohydrate in Histoplasmin. Table 4 shows 
protein and total carbohydrate detected in the various crude histoplasmins. 
Histoplasmin H-42 (1:25) appears to contain approximately 2 1/2 times 
more protein than other histoplasmins.
pH of Histoplasmin. Figure 14 shows the pH of various histoplas­
mins uséd in these investigations. Mean values were obtained using Beck­
man Zeromatic and Fisher model 210 pH meters. A gradual decrease was 
observed with increasing age in most instances. A sharp increase to pH 
6.3 was observed for histoplasmin HT-1 B-4.
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Table 4. Protein and Total Carbohydrate 
of Crude Histoplasmins.
Concentrations
Histoplasmin Protein Carbohydrate
ug/ml ug/ml
HT-1 A-5 1377 12,000
HT-1 B-5 1520 12,000
HT-2 A-5 1355 9,200
H-42(1:25) 38,500 * *
*Phenol interferes with Anthrone and Phenol-H^SO^ 
determinations, and Lowry Protein determination.
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Figure 14. Variation of pH with Increasing Age of Histoplasmin.
A = Histoplasmin HT-1 B-0 to HT-1 B-5.
B = Histoplasmin HT-2 A-0 to HT-2 A-5.
C - Histoplasmin HT-1 A-0 to HT-1 A-5.
CHAPTER IV
DISCUSSION
Disease prognosis and epidemiological investigations have 
provided the impetus for research of fungal antigens and their role in 
infection allergy. Evidence presented in this paper shows that the 
major component of crude histoplasmin active in detection of infection 
allergy can be separated and isolated from extraneous low molecular 
weight medium constituents and metabolic products. The significance 
of this achievement has already been indicated.
Previous investigations along these lines have dealt primarily 
with improvement of sérodiagnostic procedures. However, for most 
systemic mycoses sérodiagnostic techniques offer little or no insight 
with respect to disease prognosis. The only immunological tool of any 
significant value for prognosis appears to involve the mechanism of 
delayed hypersensitivity. Intradermal inoculation of various fungal 
antigens apparently reveals an antibody in most persons infected with 
homologous pathogenic fungi which closely parallels the ability of the 
patient to resist the disease. This antibody usually is considered to 
be tissue fixed, although it may exhibit limited circulatory ability due 
to its genesis. Oti the other hand, inability to demonstrate its 
circulatory existence in the hemopoietic or reticulo-endothelial system
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may result from lack of a suitable detection technique or our inability 
to interpret presently existing dcta. Electrophoretic investigations 
of convalescent sera reveal several globular proteins which have not 
been characterized and apparently are associated with various disease 
processes (42 & 46).
It is known that in endemic areas a high percentage of the 
population is exposed and infected with the etiological agent of histo­
plasmosis. Yet, only a very small percentage disseminate and progress 
to terminal disease. In the majority of cases, acquired immunological 
resistance develops and spontaneous cure results. This acquired 
immunological state apparently is of long duration and wanes only in 
the terminal years of life. Therefore, again the mechanism of delayed 
hypersensitivity lends itself to important epidemiology of public health.
Most researchers have approached the study of antigens and 
antigenicity via the yeast phase of this unique diphasic fungus. Salvin, 
et al., (35) considers that this approach is justified since the yeast- 
phase cells are manifest in the disease state. Also previous reports 
of protection against infection involved vaccines derived from the 
cell wall of the yeast phase of H. capsulatum (21 & 35). However, 
regardless of authenticity, most intracutaneous testing continues 
to utilize the mycelial growth filtrate, histoplasmin.
Previous knowledge indicates that the potency of crude histo­
plasmin is dependent upon the isolate of H. capsulatum used in its 
production. Hook, et al., (19) have suggested that antigenic specificity 
and potency might be improved through utilization of genetically homo­
geneous cultures of carefully selected isolates of fungi. The Scritchfield
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Isolate used in this study was selected for production of histoplasmins 
HT-1 A-5 and HT-1 B-5 (Table 1) because previous data (unpublished) 
indicated its superior antigenicity.
Considerable variation exists in supporting media, physical 
growth conditions and harvesting age for production of histoplasmin. 
Media containing organic nitrogenous materials such as peptone or neo­
peptone are not desirable since they elicit varying degrees of cutaneous 
reactions. These reactions are easily differentiated by their immediate 
and nonspecific character but tend to mask the desired delayed immuno­
logical response. Histoplasmins used in these investigations were 
produced in Smith's liquid asparagine medium (41) which contains the 
amino acid asparagine as the only organic source of nitrogen.
Salvin and Hottle (37) reported that maximal yield of histo­
plasmin in a glucose asparagine medium was obtained after 2 to 2 1/2 
months of growth at room temperature. The appearance of histoplasmin 
in the medium was paralleled by a rise in alkalinity to pH 8-8,5, a 
drop in reducing sugars t zero and a decrease in total nitrogen.
In contrast Figure 14 si <we decrease in pH with increased age of 
histoplasmin to 5 months. Data (Table 5) indicates concentration 
of total carbohydrate in crude histoplasmins remained essentially the 
same as initial concentration of glucose occurring in the liquid medium 
employed in production of histoplasmins (12 g/liter). However, there 
is a gradual reduction of detectable reducing sugars with increasing age 
of histoplasmin. This suggests conversion of glucose to non-reducing 
carbohydrate such as the structural component chitin and possibly skin 
test active materials.
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Several investigators have reported isolation of skin test 
active components from crude histoplasmin. However, in most cases, the 
separation and isolation procedures were time consuming and complex 
involving extremely harsh treatment of the biological product which 
was obtained in small yield. It was decided that if a suitable separation 
could be obtained by column chromatographic procedures several of these 
problems could be eliminated.
The principle of Sephadex chromatography is based on separation 
of chemical compounds differing in molecular size and thus indirectly 
molecular weight. Elution may be obtained with physiological saline 
or distilled water thus eliminating drastic pH changes or high salt 
concentrations required of ion exchange resins. The relatively mild 
treatment should increase yield especially if a labile protein or 
protein complex were involved. The simplicity of eluting fluid should 
eliminate the necessity for desalting by dialysis or other means.
One major advantage is that one obtains little dilution of the 
desired compound or component and in fact should get a concentration 
effect with Sephadex chromatography. This is amply illustrated by frac­
tionation of histoplasmin H-42 (1:25) where a 25 ml sample was applied 
to the column (Table 2) and Beta fraction collected in 10 (tube 17-27, 
Figure 3) 2.5 ml aliquots. Figure 4 shows that Beta fraction elicited 
a mean reaction of approximately 9.5 mm upon animal testing. This is 
very near the value of 11.? obtained for crude histoplasmin H-42 (1:25).
Table 2 also shows that considerable concentration of HT-1 A-5, 
HT-1 B-5 and HT-2 A-5 Beta fractions was required to elicit comparable 
skin test reactions. This re-emphasizes the potency of histoplasmin
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H-42 (1:25) and indicates the concentration of active component occurring 
in other histoplasmins. Comprehension of this point explains the tre­
mendous variation in skin test potency of crude histoplasmins and 
difficulty encountered in standardization according to presently accepted 
procedures (30 & 40).
Figures 4, 7, and 11 show a high incidence of reactions on 
test animals with fractions passing the Sephadex G-25 column late in 
the elution pattern. The characteristic brown color of histoplasmin 
was found to be associated with this peak of concentrated protein material. 
The large skin test reactions were most likely due to the large quantity 
of protein inoculated: 540 ug/test for H-42 Zeta, 220 ug/test for HT-1 
A-5 Nu and only 50 ug/test for HT-2 A-5 Zeta fraction. In contrast to 
Beta fractions these antigens elicited large reactions on control animals.
It also was observed that the resulting skin test reactions were 
not similar to those exhibited by the Beta fractions or crude histo­
plasmin h-42 (1:25). These reactions usually exhibited an immediate 
erythema or flare reaction Wi.ich increased in intensity and persisted 
for 5 to 10 days, on occasibn. progressing to the definition of an Arthus 
phenomenon. In contrast. Beta fractions and crude histoplasmin H-42 
(1:25) elicited reactions with initial appearance of induration and 
erythema at 6 to 8 hours. Reaction size characteristically reached a 
maximum between 24 to 48 hours and usually disappeared by 96 hours.
Rich (34) proposed differentiation of the two types by the 
slow development of the delayed type reaction following re-exposure to 
antigen, contrasted to the prompt appearance of the reaction in the 
Arthus-sensitized body. The above reactions were differentiated by 
this definition.
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Observation of elution patterns and chemical data in figures 
4, 7, 8, and 11 indicates H-42 Zeta fraction contains considerably more 
protein than fractions showing the second peak of animal activity in 
other histoplasmins. Table 4 shows similar results for total protein 
in crude histoplasmin H-42 (1:25) as compared to other histoplasmins.
These data are ambiguous, since crude histoplasmin H-42 was a 1 to 25 
dilution and its respective fractions were restored to initial concen­
tration. Other histoplasmin fractions were 2 to 5 fold concentrations 
of initial sample volume, thus they should contain considerably more 
protein. Subsequent findings have shown that crude histoplasmin H-42 
(1:25) contains 0.5 to 1 per cent phenol as preservative. Phenol interferes 
with the Lowry protein test and passes the Sephadex column late in the 
elution pattern. This undoubtedly explains the indicated high protein 
concentration in crude histoplasmin H-42 (1:25) and H-42 Zeta fraction. 
Protein absorption at 280 mu is based on the frequency of occurrence 
of cyclic amino acids in the protein chain, thus the cyclic structure 
of phenol passing the Sephadex column in conjunction with H-42 Zeta 
fraction apparently enhances the absorption at 280 mu.
Analytical gel exclusive chromatography (2 & 3) suggests the 
skin test active component is of relatively low molecular weight. Frac­
tionation range from Sephadex G-25 is 100 to 5000 molecular weight. This 
would indicate a molecular weight of 5000 or less for Beta fraction 
material. If this conclusion is valid, then the active component as 
a protein would consist of only 50 to 100 amino acid residues. However, 
no further attempts were made to determine molecular weight and extreme 
caution should be exercised in estimation of molecular weight from
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exclusion chromatography data for crude preparations.
Electrophoresis studies, in all cases showed 3 bands sensitive 
to ninhydrin and one sensitive to alkaline silver nitrate (47) for the 
Beta fractions. Alkaline silver nitrate, a general method for detection 
of sugar (28 & 38), suggests that the Beta fractions do not consist 
entirely of proteinacious material. Recycling also failed to eliminate 
the alkaline silver nitrate sensitive bands f-om the Beta fractions. It 
must be remembered that Sephadex gel is a dextran and that autogenous 
hydrolysis could allow slight contamination of eluate with sucrose or 
its glucose and fructose components. However, this phenomenon should 
occur only at low frequency in which case the contaminating sugar would 
appear in close proximity with exogenous glucose substrate in late low 
molecular weight fractions.
Comparison of colorimetrically estimated protein to dry weight 
of h-42 Beta fraction (HPD) also indicates that the skin test active 
component consists of material associated with protein (Table 4). These 
data indicate approximately 10% of total materials was detected as 
protein. Dayson and Evans (8) have demonstrated that deproteinization 
of skin test active antigens destroys skin test reactivity. Investi­
gators (44 & 50) have reported similar inactivation of antigens used 
in sérodiagnostic procedures. Salvin (35) reported isolation of a skin 
test active antigen from crude histoplasmin which appeared to be a 
complex containing carbohydrate and protein moieties. His electrophoretic 
data also suggested a protein fraction nearest the anode containing little 
carbohydrate was active in producing skin test reactions. Salvin in 
addition suggested that occurrence of multiple protein components in
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electrophoresis strips of active fractions probably was due to "gradual 
release of the active protein from Immobile carbohydrate."
Dayson et al. (8) reported cutaneous reactions of 5 to 7 mm 
Induration on H. capsulatum Infected rabbits with 10 ug of antigen. The 
antigenic fraction was obtained by ethanollc precipitation of yeast 
cell filtrates. Other Investigators (5, 20 & 35) have reported skin 
test reactions of approximately 10 mm Induration elicited with 10 to 
100 ug of antigen obtained by similar chemical precipitation of yeast 
cells or filtrates. Figure 12 shows that approximately 60 ug of HPD 
elicited skin test reactions of 10 ram Induration. This Is comparable 
to that elicited by crude histoplasmin H-42 (1:25).
Although other Investigations have reported antigens apparently 
active In detection of Infection allergy the procedures are expensive 
and extremely laborious. Also only small yields of active material. 
Insufficient for large scale distribution were obtained from large 
volumes of yeast cell filtrates. Past experience has shown that a 
very small percentage of crude histoplasmin lots possess sufficient 
potency to warrant standardization and subsequent distribution for skin 
test purposes. Evidence presented In this paper Indicates that yields 
of active material may be obtained rapidly and with relative ease from 
crude histoplasmins. Thus crude histoplasmin lots possessing mediocre 
skin test potency could be utilized without complete loss.
Evidence also Indicates that skin test material may be dehy­
drated to a solid state which Is easily re-dlssolved In physiological 
saline or nop-pyrogenlc distilled water. Existence of solid antigens 
reduces the laborious task of processing and standardization, reduces 
chances of contamination and enhances preservation.
CHAPTER V 
SUMMARY AND CONCLUSIONS
Numerous attempts have been made to fractionate yeast cell 
preparations or filtrates of H. capsulatum. Most investigators have 
approached this problem through ethanolic precipitation or the use 
of various cellulosic ion exchangers. These procedures are expensive, 
laborious and yield only small quantities of skin test active material 
exhibiting considerable variability.
Evidence presented in this paper indicates crude histoplasmins 
may be fractionated by Sephadex G-25 chromatography, resulting in 
quantitative yield of skin test active material. Data obtained from 
fractionations of four separate histoplasmin lots indicates the pro­
cedure is applicable in varying degrees of efficiency to histoplasmins 
of varying degrees of skin test potency.
It also appears that spectrophotometric absorption at a 
wavelength of 280 millimicrons is directly proportional to quantity of 
skin test active material occurring in various crude histoplasmins.
Colorimetric estimation of protein, carbohydrate, and electro­
phoretic data suggest that the skin test active component may be a 
protein-carbohydrate complex. Other data indicate the skin test active 
complex is either grossly contaminated with inert materials of
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approximately similar molecular weight or consists of a major component 
complexed with a protein moiety.
Attempts in past years to dehydrate crude histoplasmin to a 
dry state have been unsuccessful. Such endeavors have resulted in a
gummy colored mass which could not be restored to a liquid phase.
However, it has been possible to dehydrate the Beta fraction of crude 
histoplasmin to a powdered state. The powder is easily re-dissolved 
in sterile non-pyrogenic distilled water or physiological saline and 
apparently retains its skin test activity.
The principal contributions of these investigations have been:
1. Isolation of the skin test active component from crude histoplasmins,
2. Development of rapid and relatively simple methods applicable to 
large scale fractionation and isolation of the skin test active com­
ponent from crude histoplasmin, 3. Suggestion that the skin test 
active principle is in fact a protein-carbohydrate complex, and 4, In­
dications that dehydrated skin test active material may be quantitated 
in terms of dose weight.
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